Cytoplasmic suppression of tumorigenicity in reconstructed mouse cells

J W Shay1, H Werbin

  • 1Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas 75235.

Cancer Research
|February 15, 1988
PubMed

Insights

Nontumorigenic cytoplasm suppressed cancer development in reconstructed cells. This study identified cytoplasmic factors that inhibit tumor formation, offering new insights into cancer suppression mechanisms.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Genetics

Background:

  • Cytoplasmic suppression of tumorigenicity studies have yielded inconclusive results.
  • Previous methods used mutagens and cell dilution, complicating findings.

Purpose of the Study:

  • To investigate the role of cytoplasmic factors in suppressing tumorigenicity.
  • To overcome limitations of previous cybrid studies.

Main Methods:

  • Constructed cells using tumorigenic karyoplasts and nontumorigenic cytoplasts.
  • Employed ricin-antiricin selection for cell isolation.
  • Utilized NIH/3T3 cells and benzo(a)pyrene epoxide treatment.

Main Results:

  • Ten selected clones exhibited no tumorigenicity in nude mice.
  • Demonstrated successful suppression of induced tumorigenicity.

Conclusions:

  • Nontumorigenic mouse cell cytoplasm contains factors suppressing benzo(a)pyrene epoxide-induced tumorigenicity.
  • Findings support the presence of cytoplasmic suppressors of cancer development.